Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Tango Therapeutics, Inc.(TNGX) | 10,876,219 | 10,876,219 | 0 | $96.36M | $227.53M | 29.87% | +$131.17M |
| Kodiak Sciences Inc.(KOD) | 1,136,000 | 1,361,000 | +225,000 | $31.76M | $51.88M | 6.81% | +$20.12M |
| Revolution Medicines, Inc.(RVMD) | 400,000 | 500,000 | +100,000 | $31.86M | $48.63M | 6.38% | +$16.77M |
| Kymera Therapeutics, Inc.(KYMR) | 329,100 | 329,100 | 0 | $25.61M | $27.41M | 3.60% | +$1.80M |
| Celcuity Inc.(CELC) | 225,000 | 225,000 | 0 | $22.44M | $25.68M | 3.37% | +$3.24M |
| Surrozen, Inc.(SRZN) | 416,150 | 766,318 | +350,168 | $9.40M | $22.32M | 2.93% | +$12.92M |
| ABIVAX Société AnonymeADS(ABVX) | 125,000 | 200,000 | +75,000 | $16.86M | $22.27M | 2.92% | +$5.41M |
| Terns Pharmaceuticals Inc | 375,000 | 375,000 | 0 | $15.15M | $19.77M | 2.60% | +$4.62M |
| Vaxcyte, Inc.(PCVX) | 0 | 325,000 | +325,000 | $0 | $18.89M | 2.48% | +$18.89M |
| Capricor Therapeutics, Inc.(CAPR) | 325,000 | 590,000 | +265,000 | $9.38M | $17.94M | 2.35% | +$8.56M |
| Protagonist Therapeutics Inc | 170,000 | 170,000 | 0 | $14.85M | $17.92M | 2.35% | +$3.07M |
| Vir Biotechnology, Inc.(VIR) | 625,000 | 1,866,000 | +1,241,000 | $3.77M | $16.72M | 2.20% | +$12.95M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 0 | 1,100,000 | +1,100,000 | $0 | $16.09M | 2.11% | +$16.09M |
| Praxis Precision Medicines, Inc.(PRAX) | 46,457 | 46,457 | 0 | $13.69M | $14.97M | 1.97% | +$1.28M |
| PTC Therapeutics, Inc.(PTCT) | 200,000 | 200,000 | 0 | $15.19M | $13.63M | 1.79% | -$1.57M |
| Precigen, Inc.(PGEN) | 1,375,000 | 3,500,000 | +2,125,000 | $5.75M | $13.54M | 1.78% | +$7.80M |
| Definium Therapeutics, Inc.(DFTX) | 0 | 598,500 | +598,500 | $0 | $11.31M | 1.49% | +$11.31M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 800,000 | 800,000 | 0 | $9.66M | $11.12M | 1.46% | +$1.46M |
| uniQure N.V.SHS(QURE) | 290,000 | 662,000 | +372,000 | $6.94M | $10.82M | 1.42% | +$3.88M |
| Opus Genetics, Inc.(IRD) | 0 | 2,250,000 | +2,250,000 | $0 | $10.24M | 1.34% | +$10.24M |
| Corcept Therapeutics Incorporated(CORT) | 0 | 250,000 | +250,000 | $0 | $10.08M | 1.32% | +$10.08M |
| UroGen Pharma Ltd.(URGN) | 500,000 | 500,000 | 0 | $11.71M | $8.99M | 1.18% | -$2.72M |
| Replimune Group, Inc.(REPL) | 750,000 | 1,175,000 | +425,000 | $7.29M | $8.99M | 1.18% | +$1.70M |
| Cogent Biosciences, Inc.(COGT) | 225,000 | 225,000 | 0 | $7.99M | $8.66M | 1.14% | +$668.3K |
| Palisade Bio, Inc.(PALI) | 4,799,875 | 4,799,875 | 0 | $11.28M | $8.40M | 1.10% | -$2.88M |
| Crescent Biopharma, Inc.(CBIO) | 0 | 453,686 | +453,686 | $0 | $8.33M | 1.09% | +$8.33M |
| Soleno Therapeutics Inc | 0 | 200,000 | +200,000 | $0 | $6.70M | 0.88% | +$6.70M |
| Allogene Therapeutics Inc | 0 | 2,725,000 | +2,725,000 | $0 | $6.65M | 0.87% | +$6.65M |
| Cytokinetics, Incorporated(CYTK) | 100,000 | 100,000 | 0 | $6.35M | $6.59M | 0.87% | +$237.0K |
| Contineum Therapeutics, Inc.CL A(CTNM) | 494,000 | 494,000 | 0 | $5.65M | $6.45M | 0.85% | +$805.2K |
| Apogee Therapeutics Inc | 70,000 | 70,000 | 0 | $5.28M | $5.89M | 0.77% | +$608.3K |
| Relmada Therapeutics, Inc.(RLMD) | 0 | 842,106 | +842,106 | $0 | $5.86M | 0.77% | +$5.86M |
| Zura Bio LimitedCL A(ZURA) | 50,000 | 900,000 | +850,000 | $262.0K | $5.36M | 0.70% | +$5.09M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 275,000 | 275,000 | 0 | $3.62M | $5.13M | 0.67% | +$1.50M |
| Avalo Therapeutics, Inc.(AVTX) | 275,000 | 300,000 | +25,000 | $4.99M | $4.48M | 0.59% | -$515.0K |
| Inovio Pharmaceuticals, Inc.(INO) | 2,420,122 | 2,370,122 | -50,000 | $4.21M | $4.12M | 0.54% | -$87.0K |
| Structure Therapeutics IncADS | 75,000 | 75,000 | 0 | $5.22M | $3.62M | 0.47% | -$1.60M |
| Sarepta Therapeutics, Inc.(SRPT) | 150,000 | 150,000 | 0 | $3.23M | $3.26M | 0.43% | +$36.0K |
| Cybin D/B/A Helus Pharma(HELP) | 715,000 | 640,000 | -75,000 | $5.85M | $3.07M | 0.40% | -$2.78M |
| Ocular Therapeutix, Inc.(OCUL) | 0 | 350,000 | +350,000 | $0 | $2.96M | 0.39% | +$2.96M |
| An2 Therapeutics Inc | 0 | 749,035 | +749,035 | $0 | $2.56M | 0.34% | +$2.56M |
| Clene Inc.(CLNN) | 199,737 | 477,515 | +277,778 | $1.17M | $2.35M | 0.31% | +$1.18M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 0 | 176,500 | +176,500 | $0 | $2.24M | 0.29% | +$2.24M |
| Solid Biosciences Inc | 300,000 | 300,000 | 0 | $1.69M | $2.16M | 0.28% | +$468.0K |
| Invivyd, Inc.(IVVD) | 1,500,000 | 1,500,000 | 0 | $3.71M | $1.95M | 0.26% | -$1.75M |
| LB Pharmaceuticals Inc(LBRX) | 70,000 | 70,000 | 0 | $1.56M | $1.73M | 0.23% | +$168.0K |
| Karyopharm Therapeutics Inc.(KPTI) | 252,536 | 302,536 | +50,000 | $1.86M | $1.69M | 0.22% | -$173.5K |
| Nurix Therapeutics, Inc.(NRIX) | 100,000 | 100,000 | 0 | $1.90M | $1.55M | 0.20% | -$347.0K |
| Upstream Bio, Inc.(UPB) | 150,000 | 150,000 | 0 | $4.07M | $1.35M | 0.18% | -$2.72M |
| Milestone Pharmaceuticals Inc.(MIST) | 666,666 | 666,666 | 0 | $1.35M | $793.3K | 0.10% | -$553.3K |
| PepGen Inc.(PEPG) | 373,892 | 272,892 | -101,000 | $2.43M | $483.0K | 0.06% | -$1.95M |
| Kalvista Pharmaceuticals Inc | 20,400 | 20,400 | 0 | $329.5K | $410.7K | 0.05% | +$81.2K |
| REGENXBIO Inc.(RGNX) | 0 | 15,000 | +15,000 | $0 | $125.7K | 0.02% | +$125.7K |
| Surrozen, Inc.W EXP 08 01 203(SRZN) | 66,666 | 66,666 | 0 | $1.3K | $1.1K | 0.00% | -$266 |
| Cidara Therapeutics Inc | 53,000 | 0 | -53,000 | $11.71M | $0 | — | -$11.71M |
| Mind Medicine Mindmed Inc | 598,500 | 0 | -598,500 | $8.01M | $0 | — | -$8.01M |
| Crescent Biopharma, Inc.(CBIO) | 453,686 | 0 | -453,686 | $5.38M | $0 | — | -$5.38M |
| Nuvation Bio Inc.W EXP 02 10 202(NUVB) | 266,666 | 0 | -266,666 | $88.0K | $0 | — | -$88.0K |